Anakinra (brand name Kineret) is a biopharmaceutical drug used to treat rheumatoid arthritis. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan
The global Anakinra market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anakinra volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anakinra market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anakinra in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anakinra manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Swedish Orphan Biovitrum
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
10MIU/VIAL
18MIU/VIAL
25MIU/VIAL
Segment by Application
Pediatrics
Adults
Summary:
Get latest Market Research Reports on Anakinra. Industry analysis & Market Report on Anakinra is a syndicated market report, published as Global Anakinra Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Anakinra market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.